Researchers assessed the effect of treatment with glucocorticoids and tocilizumab in patients with severe COVID-19-associated cytokine storm syndrome.
COVID-19 is associated with hyperglycemic emergencies, particularly in patients with existing type 2 diabetes and of African ethnicity.
This is the first study to describe the safety of IL-6 blockade with intravenous sarilumab in patients with COVID-19 pneumonia with systemic hyperinflammation.
Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.
The in-hospital mortality for native valve infective endocarditis has decreased between 2002 and 2016.
A protein epitope targeted by the antibody response in children with Kawasaki disease has been identified.
